Open AccessComment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply
Author(s) -
Thomas Frisell,
Johan Askling
Publication year - 2019
Publication title -
rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.957
H-Index - 173
eISSN - 1462-0332
pISSN - 1462-0324
DOI - 10.1093/rheumatology/kez067
Subject(s) - abatacept , medicine , tocilizumab , rituximab , tofacitinib , rheumatoid arthritis , lymphoma